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Multimeric Assembly of Host-Pathogen Adhesion
Complexes Involved in Apicomplexan Invasion
May M. Paing, Niraj H. Tolia*
Department of Molecular Microbiology and Microbial Pathogenesis, Washington University School of Medicine, Saint Louis, Missouri, United States of America
Apicomplexan parasites are the causative agents of diseases that
include malaria, toxoplasmosis, and coccidiosis. These obligate
intracellular parasites have evolved to use a conserved mechanism
for host-cell invasion. The apicomplexan phylum is defined by the
presence of micronemes and rhoptries, which are distinct
organelles located at the apical end of the parasite. These
organelles secrete molecules necessary for host-cell invasion [1].
Apicomplexan parasites can invade disparate cell types, including
hepatocytes, erythrocytes, lymphocytes, macrophages, and cells
lining the digestive tract. Unlike viruses and intracellular bacteria,
apicomplexans actively invade host cells without relying on host
uptake pathways. As such, host-cell sensing and subsequent
invasion are driven entirely by the parasite in a dynamic and
rapid process. Intracellular residence protects the parasite from
immune attack and enables parasite replication prior to host-cell
lysis and subsequent invasion of neighboring host cells.
The repertoire of ligand-receptor complexes utilized by
parasites for entry into host cells is diverse. Some interactions
occur through cell-specific receptors resulting in high-affinity
interactions, while others occur through multiple lower-affinity
interactions via surface moieties found on several cell types.
Receptor-specific and general cell binding may explain host-cell
tropism of different pathogens, although additional factors are
important. There is growing evidence that multimeric assembly of
parasite ligands and host surface molecules strengthens the host-
pathogen interactions necessary for invasion. We discuss recent
work that has advanced our knowledge of the assembly of adhesive
complexes from two critical apicomplexan pathogens and
highlight areas of research that require further investigation.
Concepts That Define Multimeric Assembly of
Complexes
Affinity, avidity, and valency are necessary concepts to define
receptor-ligand interactions. The strength of attachment for two
binding partners is determined by the affinity of individual binding
sites and the number of interacting binding sites (valency). Avidity
is the accumulated strength of multiple affinities from multivalent
binding sites. The avidity of a multivalent complex is typically far
greater than the sum of the individual affinities because of
synergism between independent sites: dissociation at one site will
be compensated by a bound second site, leading to rapid
reassociation at the first site. Parasite ligands have evolved to
increase both affinity and valency, resulting in high avidity that is
necessary to create strong interactions that anchor parasites to host
cells. Further adhesion strengthening is achieved through
increased local surface concentration of ligands resulting in
multiple focused interactions. In this review, we highlight parasite
protein ligands that have evolved diverse methods to form high-
avidity complexes for invasion. Specific mechanisms include
utilizing repeat units, tandem duplication of adhesive domains,
and homo- or hetero-oligomerizing with multimeric host receptors
upon engagement.
Plasmodium Sporozoite Motility and Invasion
Plasmodium falciparum sporozoites invade the cells of the mosquito
salivary glands prior to injection into the human host. Once
injected, sporozoites migrate through the dermis, enter capillaries,
traverse Kupffer cells that form the endothelial lining of the liver,
and finally invade hepatocytes. The best-characterized invasion
complexes with roles during these processes are mediated by
thrombospondin-related anonymous protein (TRAP) and circum-
sporozoite protein (CSP).
P. falciparum TRAP (PfTRAP) has a role in sporozoite gliding
motility, salivary gland invasion, and sporozoite infectivity [2].
This adhesin is stored within micronemes and is released onto the
cell surface at the anterior tip upon contact with a host cell.
PfTRAP contains two adhesive domains: a von Willebrand factor
type A (VWA) domain and a thrombospondin type-I repeat
(TSR) domain. Attachment to host cells occurs through both the
VWA domain, which is similar to the I-domains of integrins that
are important for magnesium cation coordination, and the TSR
domain that binds to abundantly expressed heparan sulphate
proteoglycans (HSPGs) on the hepatocyte surface [3,4]. Individ-
ually, each domain or repeat binds to its respective interacting
molecule, and the overall avidity of binding is likely increased by
the tandem clustering of multiple repeats and domains
(Figure 1A).
P. falciparum CSP (PfCSP) is the most abundant antigen
expressed on the surface of sporozoites and is the major antigen
of a pre-erythrocytic malaria vaccine that confers limited
protection [5]. PfCSP is anchored to the surface via a glycosylpho-
sphatidylinositol (GPI) moiety and is crucial for sporozoite
infection of hepatocytes [6]. PfCSP shares with PfTRAP the
presence of TSR repeats [7]. The seven degenerate sulphatide
binding motifs in the PfCSP TSR repeats bind the abundantly
expressed HSPGs on host cells, resulting in high-avidity binding
driven by the tandem duplication of individual repeats.
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Plasmodium Merozoite Invasion of Red Blood Cells
The P. falciparum erythrocytic cycle begins with merozoite
recognition and invasion of red blood cells (RBCs). Initial binding
to the RBC is mediated by merozoite surface proteins (MSPs). The
most abundant of the merozoite surface proteins is the complex of
GPI-anchored MSP1 noncovalently attached to MSP6 and MSP7
[8]. MSP1 is proteolytically processed upon merozoite egress from
a previously infected host cell. The multipartite MSP1 complex
resides on the surface of the free merozoite and is shed at the time
of RBC invasion to expose the C-terminal GPI-anchored MSP119
in complex with MSP9 for RBC entry. The MSP119/MSP9
multimer likely stabilizes and enhances the avidity of binding to
the most abundant RBC membrane protein, the band 3
homodimer [9]. Engagement of band 3 is thought to be mediated
by two epidermal growth factor (EGF)-like domains in MSP119
(Figure 1B).
The erythrocyte binding like (EBL) family has a defined role in
recognition of and attachment to erythrocytes by engaging specific
erythrocyte receptors [10–12]. EBL ligands are released from
Figure 1. Multimeric assembly, clustered interactions, and molecular complexes between parasite ligands and host-cell receptors
for invasion. (A) PfTRAP engagement with heparan sulphate proteoglycans (HSPGs) on the hepatocyte surface; (B) proteolytic processing and
shedding of PfMSP1 exposes the 19 kDa fragment (MSP119) that forms an invasion complex with MSP9 and the band 3 homodimer; (C) assembly of
two PfEBA-175 monomers around dimeric glycophorin A of erythrocytes; (D) stepwise multimeric assembly of two PvDBP with two Duffy antigen/
receptor for chemokines on reticulocyte surface; (E) monomeric interaction between PfEBA-140 and glycophorin C on erythrocytes; (F) proposed
complexes of TgMIC2 and TgM2AP and of TgMIC1, TgMIC4, and TgMIC6 on the parasite surface; (G) variations in oligomeric states of GPI-anchored
surface antigens (SAGs) create distinct interaction sites.
doi:10.1371/journal.ppat.1004120.g001
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micronemes onto the apical surface of merozoites during invasion
[13]. These proteins contain one or two conserved Duffy binding
like (DBL) receptor-binding domains (Region II), a cysteine-rich
domain (Region VI), and a transmembrane domain [14]. The
EBL ligands in P. falciparum contain two DBL domains in Region
II and include PfEBA-175, PfEBA-140/BAEBL, PfEBL-1, and
PfEBA-181/JESEBL. Structural and biophysical studies have
elucidated mechanisms of receptor engagement for members of
this family.
The first member of the family to be structurally characterized
was PfEBA-175 (Figure 1C). Two PfEBA-175 monomers dimerize
around the glycosylated extracellular domains of glycophorin A
dimers [15,16], resulting in a high-avidity interaction [17,18]. The
sialylated glycans of glycophorin A are recognized by sialic acid-
binding pockets created at the interface between Region II of each
monomer [16]. The complex assembly requires both DBL
domains of each monomer and is enhanced by additional regions
of PfEBA-175 [17,18].
In P. vivax, the Duffy-binding protein (PvDBP) contains a single
DBL domain that binds to the Duffy antigen/receptor for
chemokines (DARC) (Figure 1D), a nonsignaling G-protein-
coupled receptor on reticulocytes [19–21]. Even though the
DBL domain architectures of PvDBP and PfEBA-175 are
different, these ligands have a similar mechanism of receptor
engagement. PvDBP is monomeric in the absence of DARC, and
DARC binding drives dimerization of PvDBP [22]. Examination
of multimeric assembly in solution and capture of PvDBP:DARC
complexes by crystallography revealed the formation of a
heterotrimer of two PvDBPs bound to one DARC, followed by
a heterotetramer of two PvDBPs engaging two DARCs [23].
These complexes suggest stepwise assembly, which is likely to be
cooperative, leading to a high-avidity PvDBP:DARC interaction.
The two DBL domains of PfEBA-140 Region II independently
bind to sialylated glycans of glycophorin C on erythrocytes [24–
26]. While PfEBA-175 and PvDBP dimerize upon receptor
engagement, PfEBA-140 may contact glycophorin C as a
monomer (Figure 1E) [25,26]. Additional studies are necessary
to examine if multimeric assembly occurs upon receptor binding
or if oligomerization is an important determinant of receptor
specificity. PfEBA-140 Region II has also evolved novel glycan-
binding pockets, distinct from those in PfEBA-175, and these do
not require dimerization [25,26].
Disruption of multimeric assembly is an effective method for
antibody neutralization of parasite growth. An antibody that binds
to the PfEBA-175 dimer interface and receptor-binding sites
effectively disrupts binding to glycophorin A and blocks P.
falciparum invasion [27–29]. Similarly, the residues at the dimer
interface and DARC-binding groove are targeted by naturally
acquired antibodies correlated with disruption of PvDBP binding
[22,23,30]. These studies suggest that assembly of ligands around
receptors leading to high-avidity interactions is an important
determinant of receptor binding and that immune targeting of
oligomeric interfaces in addition to receptor-binding pockets leads
to protection.
Multimeric Micronemal Protein Complexes of
Toxoplasma gondii
The microneme proteins (MICs) in Toxoplasma gondii preassem-
ble in the endoplasmic reticulum and form complexes prior to
transiting to the micronemes. The propensity to form oligomers
with different combinations of partners likely allows the parasite to
expand the receptor repertoire or fine-tune the specificity of
receptor binding. To date, three major complexes have been
identified and functionally characterized in T. gondii attachment to
host cells. First, microneme protein 2 (TgMIC2), a member of the
conserved TRAP family, is found in a heterohexameric complex
with MIC2-associated protein (TgM2AP) (Figure 1F) and plays a
fundamental role in gliding motility and host-cell attachment
[31,32]. Each TgMIC2 monomer binds one TgM2AP monomer
via the TSR repeats in TgMIC2 [33]. Second, TgMIC8, which
complexes with the lectin-like TgMIC3, is essential for rhoptry
secretion and invasion [34]. Third, TgMIC6 forms a multimeric
complex with two adhesins, TgMIC1 and TgMIC4, and
contributes to invasion in vitro and virulence in vivo [35–37].
The TgMIC1:4:6 complex has been the most characterized
structurally (Figure 1F). Although TgMIC1 was classified as a
TRAP family member, structural studies of the N-terminal repeat
units and C-terminal domain have revealed novel adhesion
modules [36,38]. The C-terminal galectin-like domain of TgMIC1
stabilizes the interaction with the EGF domains of TgMIC6,
which in turn anchors the complex via a transmembrane domain
[37,38]. The N-terminus of TgMIC1 contains two micronemal
adhesive repeats (MAR) that bind sialic acid [39]. TgMIC1 forms
a disulfide-linked trimer, and each TgMIC1 monomer further
engages a TgMIC4 monomer, creating a heterohexamer. The two
tandem apple domains of TgMIC4 bind galactose-containing
glycans [39]. The duplication of MAR repeats and apple domains,
coupled with heterohexamerization, likely results in high avidity
by increased valency for sialic acid and galactose.
Toxoplasma Surface Antigens
Surface antigen glycoproteins (SAGs) and SAG-related se-
quence proteins (SRS) are abundant and widely distributed GPI-
anchored adhesins on the T. gondii surface at multiple stages of the
life cycle [40–43]. They are optimally positioned for low-affinity,
lateral interactions with the host-surface glycosaminoglycans,
which act as receptors for Toxoplasma invasion [44,45]. Crystal
structures of SAGs revealed varying levels of dimerization: SAG1
forms a parallel homodimer with an extensive dimer interface
[46], Bradyzoite-specific surface antigen (BRS4) exhibits a smaller
dimer interface [47], while the SAG expressed in sporozoite stage
(SporoSAG) is monomeric (Figure 1G) [48]. Variation in
oligomeric state may impact receptor binding as the SAG1 and
BRS4 dimers create basic pockets implicated in glycosaminogly-
can engagement. The basic pocket is replaced by an acidic cap in
SporoSAG, and the receptor moiety engaged is unclear. It is
plausible that, like EBL-ligands, receptor binding induces or
stabilizes dimerization of SAGs, although further structural studies
in solution are necessary.
In summary, the organization of parasite ligands at the site of
invasion is promoted by multivalent, high-avidity interactions with
host-cell receptors and surface moieties. The strength of attach-
ment can be further increased by clustering of adhesive complexes.
This combination of clustered interactions and multimeric
complexes not only ensures the parasite’s successful entry into
the host cell but also likely promotes evasion from the host’s
immune response by burying potentially protective antigenic
epitopes. Increased avidity has been demonstrated for some but
not all multivalent complexes, and future studies are necessary to
clearly identify the effect of multimeric assembly on binding and
avidity in cases in which this information is lacking. Assembly can
also activate or enhance downstream signaling processes in other
systems, and further studies are needed to decipher whether
signaling is triggered by multimeric assembly during invasion. The
structural determination of critical interfaces in ligand-receptor
binding and the biochemical and biophysical elucidation of
PLOS Pathogens | www.plospathogens.org 3 June 2014 | Volume 10 | Issue 6 | e1004120
multimeric assembly mechanisms will provide novel perspectives
on how the invasion process is manifested and regulated. This
information will identify novel ways to block pathogen entry into
host cells.
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